No Prescription |
 |
 | ||
|
Elogen Mircette |
|
| ||
No Prescription » Prescription Drugs 7 » Elogen Mircette Oral contraceptives (birth-control pills) are used to prevent pregnancy. Estrogen and progestin are two female sex hormones. Combinations of estrogen and progestin work by preventing ovulation (the release of eggs from the ovaries). They also change the lining of the uterus (womb) to prevent pregnancy from developing and change the mucus at the cervix (opening of the uterus) to prevent sperm (male reproductive cells) from entering. Oral contraceptives are a very effective method of birth control but they do not prevent the spread of human immunodeficiency virus (HIV the virus that causes acquired immunodeficiency syndrome [AIDS]) and other sexually transmitted diseases.Some brands of oral contraceptives are also used to treat acne in certain patients. Oral contraceptives treat acne by decreasing the amounts of certain natural substances that can cause acne.One type of oral contraceptives (Yaz) is also used to relieve the symptoms of premenstrual dysphoric disorder (physical and emotional symptoms that occur before the menstrual period each month) in women who have chosen to use an oral contraceptive to prevent pregnancy. Buy Elogen Mircette and other Prescription Drugs 7 products online at Medstore. Buy Online at Medstore - Click Here!
About Elogen Mircette: Product Type: Prescription Drugs 7 Elogen (Mircette Apri Azurette Cesia Cyclessa Kariva Ortho-cept Reclipsen Velivet Generic Desogesterl Ethinyl Estradiol) Elogen (Mircette Apri Azurette Cesia Cyclessa Kariva Ortho-cept Reclipsen Velivet Generic Desogesterl Ethinyl Estradiol) Mircette Apri Azurette Cesia Cyclessa Kariva Ortho-cept Reclipsen Velivet Generic Desogesterl Ethinyl Estradiol 0.15/0.02mg 21 Tablets 63(3 x 21) Tablets 126(6 x 21) Tablets Mircette Apri Azurette Cesia Cyclessa Kariva Ortho-cept Reclipsen Velivet Generic Desogesterl Ethinyl Estradiol Elogen
View more Prescription Drugs 7 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
